Reaction Details |
| Report a problem with these data |
Target | Breakpoint cluster region protein [1-693] |
---|
Ligand | BDBM111467 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Kinase Assays |
---|
IC50 | 3578±n/a nM |
---|
Citation | Pan, X; Dong, J; Gao, H; Wang, F; Zhang, Y; Wang, S; Zhang, J Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors. Chem Biol Drug Des83:592-9 (2014) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Breakpoint cluster region protein [1-693] |
---|
Name: | Breakpoint cluster region protein [1-693] |
Synonyms: | BCR | BCR1 | BCR_HUMAN | Bcr-Abl | D22S11 |
Type: | Protein |
Mol. Mass.: | 76683.66 |
Organism: | Homo sapiens (Human) |
Description: | P11274[1-693] |
Residue: | 693 |
Sequence: | MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERCKASIRRLEQEVNQERFRMIYLQ
TLLAKEKKSYDRQRWGFRRAAQAPDGASEPRASASRPQPAPADGADPPPAEEPEARPDGE
GSPGKARPGTARRPGAAASGERDDRGPPASVAALRSNFERIRKGHGQPGADAEKPFYVNV
EFHHERGLVKVNDKEVSDRISSLGSQAMQMERKKSQHGAGSSVGDASRPPYRGRSSESSC
GVDGDYEDAELNPRFLKDNLIDANGGSRPPWPPLEYQPYQSIYVGGMMEGEGKGPLLRSQ
STSEQEKRLTWPRRSYSPRSFEDCGGGYTPDCSSNENLTSSEEDFSSGQSSRVSPSPTTY
RMFRDKSRSPSQNSQQSFDSSSPPTPQCHKRHRHCPVVVSEATIVGVRKTGQIWPNDGEG
AFHGDADGSFGTPPGYGCAADRAEEQRRHQDGLPYIDDSPSSSPHLSSKGRGSRDALVSG
ALESTKASELDLEKGLEMRKWVLSGILASEETYLSHLEALLLPMKPLKAAATTSQPVLTS
QQIETIFFKVPELYEIHKEFYDGLFPRVQQWSHQQRVGDLFQKLASQLGVYRAFVDNYGV
AMEMAEKCCQANAQFAEISENLRARSNKDAKDPTTKNSLETLLYKPVDRVTRSTLVLHDL
LKHTPASHPDHPLLQDALRISQNFLSSINEEIT
|
|
|
BDBM111467 |
---|
n/a |
---|
Name | BDBM111467 |
Synonyms: | 4-Methyl-3-(4-(pyridin-3-yl) pyrimidin-2-ylamino)-N-(thiazol-2-yl) benzamide (A20) |
Type | Small organic molecule |
Emp. Form. | C21H18N6OS |
Mol. Mass. | 402.472 |
SMILES | Cc1ccc(cc1Nc1nccc(n1)-c1cccnc1)C(=O)NCc1nccs1 |
Structure |
|